TYRA Tyra Biosciences, Inc.
Nasdaq · SEC CIK 1863127 · EDGAR
- Bought, last 12 months
- $20.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $10.59M 8 sales by 3 insiders
- Filings on record
- 172 since 2021-09-17, latest 2026-09-17 19:29
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MORE ROBERT J | Dir | — | $5.25M |
| Bensen Daniel | Chief Discovery Off | — | $4.81M |
| KAPLAN GILLA | Dir | — | $528.5K |
| Verjee Rehan | Dir | $20.0K | — |
| Rueb Yuliya | VP, Fin (PAO) | — | — |
| Warner Douglas J | Chief Medical Off | — | — |
| Ashar Bhavesh | COO | — | — |
| Harris Todd | Pres, CEO, Dir | — | — |
| Fuhrman Alan | CFO | — | — |
Transactions 129
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 19:29 | 2026-09-15 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $9.13 | +864 | 1.44M | +0.1% | +$7,887 | |
| 2026-09-17 19:26 | 2026-09-15 | TYRA | Rueb Yuliya | VP, Fin (PAO) | A - Grant | $9.13 | +2,925 | 11.3K | +35% | +$26.7K | |
| 2026-09-17 19:25 | 2026-09-15 | TYRA | Fuhrman Alan | CFO | A - Grant | $9.13 | +951 | 37.1K | +3% | +$8,682 | |
| 2026-09-11 16:30 | 2026-09-09 | TYRA | Verjee Rehan | Dir | P - Purchase | $20.58 | +971.89 | 971.89 | New | +$20.0K | |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Warner Douglas J | Chief Medical Off | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Fuhrman Alan | CFO | A - Grant | $0.00 | +20.0K | 36.2K | +124% | $0 |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $0.00 | +79.0K | 1.44M | +6% | $0 |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Ashar Bhavesh | COO | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Rueb Yuliya | VP, Fin (PAO) | A - Grant | $0.00 | +8,333 | 43.4K | +24% | $0 |
| D | 2026-03-27 | 2026-03-25 | TYRA | KAPLAN GILLA | Dir | S - Sale+OE | $36.97 | -14.3K | 28.2K | -34% | -$528.5K |
| DM | 2026-03-27 | 2026-03-25+ | TYRA | KAPLAN GILLA | Dir | M - OptEx | $2.25 | -38.9K | 81.4K | -32% | -$87.5K |
| D | 2026-03-27 | 2026-03-26 | TYRA | KAPLAN GILLA | Dir | D - Sale to Iss | $37.75 | -53.2K | 28.2K | -65% | -$2.01M |
| 2026-03-17 | 2026-03-13 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $9.13 | +1,463 | 1.36M | +0.1% | +$13.4K | |
| 2026-03-17 | 2026-03-13 | TYRA | Fuhrman Alan | CFO | A - Grant | $9.13 | +1,376 | 16.2K | +9% | +$12.6K | |
| MT | 2026-02-13 | 2026-02-12 | TYRA | Bensen Daniel | Chief Discovery Off | S - Sale | $32.87 | -8,000 | 147.0K | -5% | -$263.0K |
| MT | 2026-01-20 | 2026-01-12 | TYRA | Bensen Daniel | Chief Discovery Off | S - Sale | $28.52 | -8,000 | 155.0K | -5% | -$228.2K |
| TI | 2025-12-19 | 2025-12-19 | TYRA | MORE ROBERT J | Dir | S - Sale | $25.00 | -10.0K | 3.82M | -0.3% | -$250.0K |
| T | 2025-12-16 | 2025-12-12 | TYRA | Bensen Daniel | Chief Discovery Off | S - Sale | $22.64 | -8,000 | 163.0K | -5% | -$181.1K |
| TI | 2025-11-25 | 2025-11-21 | TYRA | MORE ROBERT J | Dir | S - Sale | $20.25 | -246.9K | 3.83M | -6% | -$5.00M |
| MT | 2025-11-19 | 2025-11-18+ | TYRA | Bensen Daniel | COO | S - Sale | $16.17 | -125.6K | 220.9K | -36% | -$2.03M |
| MT | 2025-11-17 | 2025-11-13+ | TYRA | Bensen Daniel | COO | S - Sale | $16.04 | -131.4K | 426.9K | -24% | -$2.11M |
| 2025-09-17 | 2025-09-15 | TYRA | Fuhrman Alan | CFO | A - Grant | $9.13 | +701 | 14.8K | +5% | +$6,400 | |
| M | 2025-06-20 | 2025-06-17+ | TYRA | KAPLAN GILLA | Dir | S - Sale | $9.78 | -9,578 | 37.8K | -20% | -$93.7K |
| MI | 2025-06-16 | 2025-06-12+ | TYRA | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $10.19 | +163.3K | 10.25M | +2% | +$1.66M |
| M | 2025-06-16 | 2025-06-12+ | TYRA | KAPLAN GILLA | Dir | S - Sale | $10.32 | -51.8K | 37.8K | -58% | -$534.7K |
| I | 2025-06-11 | 2025-06-09 | TYRA | RA Capital Healthcare Fund LP | Dir, 10% | P - Purchase | $10.19 | +186.8K | 10.10M | +2% | +$1.90M |
| MI | 2025-06-06 | 2025-06-04+ | TYRA | Kolchinsky Peter | Dir, 10% | P - Purchase | $9.70 | +1.21M | 9.91M | +14% | +$11.75M |
| 2025-03-18 | 2025-03-14 | TYRA | Fuhrman Alan | CFO | A - Grant | $9.78 | +1,238 | 14.1K | +10% | +$12.1K | |
| 2025-03-18 | 2025-03-14 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $9.78 | +1,241 | 1.36M | +0.1% | +$12.1K | |
| MI | 2025-02-07 | 2025-02-05 | TYRA | Kjellson Nina S | Dir | S - Sale | $13.76 | -5,401 | 443.9K | -1% | -$74.3K |
| I | 2025-01-27 | 2025-01-23 | TYRA | Kjellson Nina S | Dir | S - Sale | $16.26 | -4,825 | 3.70M | -0.1% | -$78.5K |
| MI | 2025-01-21 | 2025-01-16+ | TYRA | Kjellson Nina S | Dir | S - Sale | $16.36 | -25.0K | 3.71M | -0.7% | -$409.7K |
| MI | 2024-11-26 | 2024-11-25 | TYRA | Kjellson Nina S | Dir | S - Sale | $16.84 | -5,272 | 448.7K | -1% | -$88.8K |
| I | 2024-11-13 | 2024-11-08 | TYRA | RA Capital Healthcare Fund LP | Dir, 10% | P - Purchase | $16.25 | +1.22M | 8.70M | +16% | +$19.84M |
| MI | 2024-11-08 | 2024-11-06+ | TYRA | Kjellson Nina S | Dir | S - Sale | $17.22 | -74.6K | 451.6K | -14% | -$1.28M |
| MI | 2024-11-06 | 2024-11-04+ | TYRA | Kjellson Nina S | Dir | S - Sale | $16.79 | -11.6K | 458.4K | -2% | -$194.3K |
| MI | 2024-11-01 | 2024-10-30+ | TYRA | Kjellson Nina S | Dir | S - Sale | $16.46 | -138.7K | 3.93M | -3% | -$2.28M |
| 2024-11-01 | 2024-10-30 | TYRA | Fuhrman Alan | CFO | P - Purchase | $16.00 | +9,500 | 12.8K | +284% | +$152.0K | |
| DI | 2024-10-22 | 2024-10-18 | TYRA | Boxer Capital Management, LLC | See remarks | D - Sale to Iss | — | -2.00M | 4.45M | -31% | — |
| MT | 2024-10-22 | 2024-10-18+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $27.28 | -62.7K | 1.37M | -4% | -$1.71M |
| DI | 2024-10-22 | 2024-10-18 | TYRA | Kolchinsky Peter | Dir, 10% | J - Other | — | -1.00M | 7.48M | -12% | — |
| MT | 2024-10-17 | 2024-10-15+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $25.77 | -58.7K | 1.44M | -4% | -$1.51M |
| T | 2024-10-02 | 2024-09-30 | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $24.00 | -500 | 1.48M | -0.0% | -$12.0K |
| MT | 2024-09-25 | 2024-09-23+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $24.11 | -11.7K | 1.48M | -0.8% | -$283.3K |
| MT | 2024-09-20 | 2024-09-18+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $24.19 | -16.3K | 1.50M | -1% | -$394.4K |
| 2024-09-17 | 2024-09-13 | TYRA | Fuhrman Alan | CFO | A - Grant | $12.48 | +954 | 3,349 | +40% | +$11.9K | |
| 2024-09-17 | 2024-09-13 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,350 | 1.51M | +0.1% | +$8,883 | |
| D | 2024-06-18 | 2024-06-13 | TYRA | KAPLAN GILLA | Dir | M - OptEx | $0.61 | +61.4K | 89.6K | +217% | +$37.4K |
| MT | 2024-06-10 | 2024-06-07+ | TYRA | Bensen Daniel | COO | S - Sale | $20.00 | -3,702 | 428.0K | -0.9% | -$74.0K |
| 2024-03-19 | 2024-03-15 | TYRA | Fuhrman Alan | CFO | A - Grant | $12.48 | +932 | 2,395 | +64% | +$11.6K | |
| 2024-03-19 | 2024-03-15 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,880 | 1.50M | +0.1% | +$12.4K | |
| 2024-03-19 | 2024-03-15 | TYRA | Tada Hiroomi | Chief Medical Off | A - Grant | $6.58 | +1,968 | 86.4K | +2% | +$12.9K | |
| T | 2024-03-13 | 2024-03-11 | TYRA | Bensen Daniel | COO | S - Sale | $20.00 | -200 | 431.7K | -0.0% | -$4,000 |
| MT | 2024-03-08 | 2024-03-06+ | TYRA | Bensen Daniel | COO | S - Sale | $20.09 | -1,801 | 431.9K | -0.4% | -$36.2K |
| MT | 2024-03-05 | 2024-03-01+ | TYRA | Bensen Daniel | COO | S - Sale | $20.06 | -9,152 | 434.9K | -2% | -$183.6K |
| MT | 2024-02-29 | 2024-02-27+ | TYRA | Bensen Daniel | COO | S - Sale | $20.09 | -8,644 | 444.9K | -2% | -$173.6K |
| T | 2024-02-14 | 2024-02-12 | TYRA | Bensen Daniel | COO | S - Sale | $20.00 | -1,501 | 451.5K | -0.3% | -$30.0K |
| T | 2024-02-09 | 2024-02-07 | TYRA | Bensen Daniel | COO | S - Sale | $18.09 | -9,587 | 453.0K | -2% | -$173.4K |
| DI | 2024-02-08 | 2024-02-06 | TYRA | Boxer Capital, LLC | See Remarks | A - Grant | $13.01 | +63.4K | 85.9K | +281% | +$825.0K |
| DI | 2024-02-08 | 2024-02-06 | TYRA | Shah Rajeev M. | Dir, 10% | A - Grant | $13.01 | +3.18M | 8.48M | +60% | +$41.37M |
| DMT | 2024-02-06 | 2024-02-02+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.63 | -90.8K | 480.3K | -16% | -$1.51M |
| DT | 2024-02-06 | 2024-02-02 | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +25.4K | 553.4K | +5% | +$15.5K |
| MT | 2024-02-06 | 2024-02-02+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $16.56 | -100.0K | 1.52M | -6% | -$1.66M |
| 2023-09-19 | 2023-09-15 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,421 | 1.60M | +0.1% | +$9,350 | |
| 2023-09-19 | 2023-09-15 | TYRA | Fuhrman Alan | CFO | A - Grant | $12.50 | +1,463 | 1,463 | New | +$18.3K | |
| 2023-09-19 | 2023-09-15 | TYRA | Tada Hiroomi | Chief Medical Off | A - Grant | $6.58 | +1,337 | 84.5K | +2% | +$8,797 | |
| DM | 2023-07-21 | 2023-07-19+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.01 | -4,107 | 528.0K | -0.8% | -$65.8K |
| DM | 2023-07-21 | 2023-07-19+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +4,107 | 531.9K | +0.8% | +$2,505 |
| DM | 2023-07-17 | 2023-07-13+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.05 | -2,400 | 528.0K | -0.5% | -$38.5K |
| DM | 2023-07-17 | 2023-07-13+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +2,400 | 529.9K | +0.5% | +$1,464 |
| DM | 2023-07-12 | 2023-07-10+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +1,903 | 528.5K | +0.4% | +$1,161 |
| DM | 2023-07-12 | 2023-07-10+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.04 | -1,903 | 528.0K | -0.4% | -$30.5K |
| DM | 2023-07-03 | 2023-06-29+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +40.4K | 546.8K | +8% | +$24.6K |
| DM | 2023-07-03 | 2023-06-29+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.70 | -40.4K | 528.0K | -7% | -$674.1K |
| DM | 2023-06-28 | 2023-06-26+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +46.8K | 544.0K | +9% | +$28.5K |
| DM | 2023-06-28 | 2023-06-26+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.86 | -46.8K | 536.1K | -8% | -$788.7K |
| M | 2023-06-26 | 2023-06-22+ | TYRA | Harris Todd | CEO, Dir | S - Sale | $17.01 | -24.2K | 1.60M | -1% | -$411.5K |
| M | 2023-06-21 | 2023-06-16+ | TYRA | Harris Todd | CEO, Dir | S - Sale | $17.12 | -75.8K | 1.63M | -4% | -$1.30M |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.11 | -18.3K | 528.0K | -3% | -$295.4K |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +18.3K | 540.6K | +4% | +$11.2K |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.08 | -20.7K | 1.70M | -1% | -$332.9K |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +20.7K | 1.71M | +1% | +$46.6K |
| D | 2023-04-05 | 2023-04-03 | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.13 | -2,000 | 1.70M | -0.1% | -$32.3K |
| D | 2023-04-05 | 2023-04-03 | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +2,000 | 1.70M | +0.1% | +$4,500 |
| DM | 2023-04-03 | 2023-03-30+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +4,400 | 530.0K | +0.8% | +$2,684 |
| DM | 2023-04-03 | 2023-03-30+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.08 | -4,400 | 528.0K | -0.8% | -$70.7K |
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +4,327 | 1.70M | +0.3% | +$9,736 |
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.08 | -4,327 | 1.70M | -0.3% | -$69.6K |
| DM | 2023-03-29 | 2023-03-27+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.03 | -13.6K | 528.0K | -3% | -$217.8K |
| DM | 2023-03-29 | 2023-03-27+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +13.6K | 531.3K | +3% | +$8,284 |
| DM | 2023-03-28 | 2023-03-24+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.00 | -5,912 | 1.70M | -0.3% | -$94.6K |
| DM | 2023-03-28 | 2023-03-24+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +5,912 | 1.70M | +0.3% | +$13.3K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +19.2K | 1.70M | +1% | +$43.3K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.00 | -19.2K | 1.70M | -1% | -$307.8K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +22.7K | 542.1K | +4% | +$13.9K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.00 | -22.7K | 528.0K | -4% | -$363.6K |
| 2023-03-17 | 2023-03-15 | TYRA | Tada Hiroomi | Chief Medical Off | A - Grant | $6.58 | +1,893 | 83.1K | +2% | +$12.5K | |
| 2023-03-17 | 2023-03-15 | TYRA | Harris Todd | CEO, Dir | A - Grant | $6.58 | +1,808 | 1.70M | +0.1% | +$11.9K | |
| 2023-02-23 | 2023-02-21 | TYRA | Patel Piyush R. | Chief Development Off | G - Gift | $0.00 | -8,442 | 73.8K | -10% | $0 | |
| M | 2023-02-13 | 2023-02-09+ | TYRA | Davis Aaron I. | 10% | S - Sale | $13.17 | -265.6K | 22.5K | -92% | -$3.50M |
Purchase Sale Sale after option exercise All abbreviations